Logo

Tm Bioscience Pockets $7.2M in Debenture Financing Round

Nov 15, 2004

NEW YORK, Nov. 15 (GenomeWeb News) - Tm Bioscience has pocketed CA$8.6 million ($7.2 million) in a secured debenture financing round, the company said today.

 

The financing, led by Wellington Financial and Canadian Medical Discoveries Fund, helped Tm to pay down CA$2.1 million from an outstanding loan made by CMDF.

 

The company added that the net proceeds of the latest financing will be used for general corporate purposes.

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.